12/13
07:01 am
gnlx
Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright
Medium
Report
Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright
11/15
08:03 am
gnlx
Genelux Co. (NASDAQ: GNLX) had its price target lowered by analysts at HC Wainwright from $32.00 to $30.00. They now have a "buy" rating on the stock.
High
Report
Genelux Co. (NASDAQ: GNLX) had its price target lowered by analysts at HC Wainwright from $32.00 to $30.00. They now have a "buy" rating on the stock.
11/15
05:46 am
gnlx
These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts [Yahoo! Finance]
High
Report
These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts [Yahoo! Finance]
11/14
04:17 pm
gnlx
Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates [Yahoo! Finance]
High
Report
Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates [Yahoo! Finance]
11/14
04:05 pm
gnlx
Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates
High
Report
Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates
11/6
04:01 pm
gnlx
Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference
Medium
Report
Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference
10/29
07:09 am
gnlx
Genelux Co. (NASDAQ: GNLX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $8.00 price target on the stock.
Low
Report
Genelux Co. (NASDAQ: GNLX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $8.00 price target on the stock.
10/22
04:01 pm
gnlx
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer
High
Report
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer
11/14/2024
04:05 pm
gnlx
genelux corporation
IN-LINE
Report
-18.9%
genelux corporation
8/14/2024
04:05 pm
gnlx
genelux corporation
MISS
Report
-1.4%
genelux corporation
4/1/2024
07:00 am
gnlx
genelux corporation
MISS
Report
-20.6%
genelux corporation
12/20
08:50 pm
gnlx
Form 4 GENELUX Corp For: Dec 18 Filed by: Smalling Ralph
Low
Report
Form 4 GENELUX Corp For: Dec 18 Filed by: Smalling Ralph
12/20
08:48 pm
gnlx
Form 4 GENELUX Corp For: Dec 18 Filed by: Ryder Sean
Low
Report
Form 4 GENELUX Corp For: Dec 18 Filed by: Ryder Sean
12/20
08:47 pm
gnlx
Form 4 GENELUX Corp For: Dec 18 Filed by: Yu Yong
Low
Report
Form 4 GENELUX Corp For: Dec 18 Filed by: Yu Yong
12/20
08:46 pm
gnlx
Form 4 GENELUX Corp For: Dec 18 Filed by: Cappello Joseph
Low
Report
Form 4 GENELUX Corp For: Dec 18 Filed by: Cappello Joseph
12/20
08:45 pm
gnlx
Form 4 GENELUX Corp For: Dec 18 Filed by: Zak Lourie S.
Low
Report
Form 4 GENELUX Corp For: Dec 18 Filed by: Zak Lourie S.
12/20
08:44 pm
gnlx
Form 4 GENELUX Corp For: Dec 18 Filed by: Zindrick Thomas
Low
Report
Form 4 GENELUX Corp For: Dec 18 Filed by: Zindrick Thomas
12/18
04:35 pm
gnlx
Form 4 GENELUX Corp For: Dec 16 Filed by: Zak Lourie S.
Medium
Report
Form 4 GENELUX Corp For: Dec 16 Filed by: Zak Lourie S.
12/18
04:35 pm
gnlx
Form 4 GENELUX Corp For: Dec 16 Filed by: Smalling Ralph
Medium
Report
Form 4 GENELUX Corp For: Dec 16 Filed by: Smalling Ralph
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register